Interaction of RSK2 with 5-HT2A receptor
Interaction of RSK2 with 5-HT2A receptor
批准号:
6585422
负责人:
DOUGLAS J SHEFFLER
金额:
$3.28万
依托单位国家:
美国
项目类别:
财政年份:
2002
资助国家:
美国
项目状态:
已结题
起止时间:
2002-12-01 至 2004-11-30
关键词:
binding sites biological signal transduction cell line confocal scanning microscopy disease /disorder etiology enzyme activity genetic disorder human genetic material tag immunocytochemistry immunoprecipitation mental retardation mitogen activated protein kinase predoctoral investigator protein kinase protein protein interaction psychosis receptor binding serotonin receptor site directed mutagenesis skeletal disorder syndrome yeast two hybrid system
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The goal of the proposed research is to verify the interaction of RSK2 with the third intracellular loop of the 5-HT2A receptor that was identified in a yeast-2-hybrid screen. Once this interaction has been established, its functional significance will be determined. Our central hypothesis is that RSK2 interacts with the 5-HT2A receptor, indicating a role in signal transduction. It is likely that this interaction plays a role in the ligand-dependent activation of the MAP Kinase cascade by the 5-HT2A receptor. Inactivating mutations in the RSK2 gene are responsible for the human Coffin-Lowry syndrome. This syndrome is characterized by severe non-specific mental retardation, psychosis, and progressive skeletal deformations. The psychosis that is present in Coffin-Lowry syndrome may prove to be attributed to a disfunction of 5-HT2A signaling. To test this central idea we propose to verify the interaction of the 5-HT2A receptor's third intracellular loop and RSK2 via coimmunoprecipitation studies and through confocal microscopy studies. The binding site of RSK2 to the 5-HT2A receptor will be defined via site-directed mutageneis studies in conjunction with 2-hybrid analysis. The functional role of the interaction between RSK2 and the 5-HT2A receptor will be defined.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Optimization of Drug-like Properties of CRFBP-CRF2 Negative Allosteric Modulators for Alcohol Use Disorder
-
批准号:10804469
-
项目类别:
-
资助金额:$85.11万
-
财政年份:2023
-
负责人:DOUGLAS J SHEFFLER
-
依托单位:
Lead optimization of novel CRFBP-CRFR2 complex modulators for alcohol use disorder
-
批准号:9920651
-
项目类别:
-
资助金额:$83.6万
-
财政年份:2019
-
负责人:DOUGLAS J SHEFFLER
-
依托单位:
Lead optimization of novel CRFBP-CRFR2 complex modulators for alcohol use disorder
-
批准号:10132945
-
项目类别:
-
资助金额:$73.34万
-
财政年份:2019
-
负责人:DOUGLAS J SHEFFLER
-
依托单位:
Interaction of RSK2 with 5-HT2A receptor
-
批准号:6659665
-
项目类别:
-
资助金额:$3.54万
-
财政年份:2002
-
负责人:DOUGLAS J SHEFFLER
-
依托单位:
海外基金